Zobrazeno 1 - 10
of 118
pro vyhledávání: '"William D. Spotnitz"'
Autor:
Brian A. Bruckner MD, William D. Spotnitz MD, Erik Suarez MD, Matthias Loebe MD, PhD, Uy Ngo PA, Daniel L. Gillen PhD, Roberto J. Manson MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
This clinical study compares 2 hemostatic agents, a novel combination powder (CP) (HEMOBLAST ™ Bellows) and an established polysaccharide starch powder (PP) (Arista ™ AH) to assess the usefulness of CP. Retrospective comparative analysis of CP (J
Externí odkaz:
https://doaj.org/article/5eb3020177dd4241a0473a1c8d876a94
Autor:
Daniel J. Del Gaizo MD, William D. Spotnitz MD, Rachel W. Hoffman BSE, Mark Christopher Hermann MD, Linda S. Sher MD, Russell H. Spotnitz MD, Yuri S. Genyk MD, Ian J. Schorn BSE, Daniel L. Gillen PhD, Bobby L. White PA-C, Bruce G. Miller, Roberto J. Manson MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
The SPOT GRADE (SG), a Surface Bleeding Severity Scale, is a unique visual method for assessing bleeding severity based on quantitative determinations of blood flow. This study assessed the reliability of the SG scale in a clinical setting and collec
Externí odkaz:
https://doaj.org/article/a7800c8f952d4fd1ae8498834a9cae0c
Publikováno v:
Statistics in Medicine. 39:1941-1951
We present a methodology motivated by a controlled trial designed to validate SPOT GRADE, a novel surgical bleeding severity scale. Briefly, the study was designed to quantify inter- and intra-surgeon agreement for characterizing the severity of surg
Autor:
Ian J Schorn, Daniel L. Gillen, Valerie Centis, Grant V. Bochicchio, Shankar Lakshman, Abbas Ardehali, Nick C Dang, Russell H Spotnitz, Steven A. Olson, Mark Christopher Hermann, Rachel W Hoffman, William D. Spotnitz
Publikováno v:
Journal of Cardiac Surgery. 34:50-62
The safety and efficacy of a hemostatic powder (HP) versus a control agent, absorbable gelatin sponge and thrombin (G + T), were assessed, using a validated, quantitative bleeding severity scale.Subjects were randomized to receive HP (256 subjects) o
Autor:
Russell H Spotnitz, Mark Christopher Hermann, William D. Spotnitz, Bruce G Miller, Bobby L White, Daniel J. Del Gaizo, Linda Sher, Ian J Schorn, Rachel W Hoffman, Roberto J. Manson, Daniel L. Gillen, Yuri Genyk
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
The SPOT GRADE (SG), a Surface Bleeding Severity Scale, is a unique visual method for assessing bleeding severity based on quantitative determinations of blood flow. This study assessed the reliability of the SG scale in a clinical setting and collec
Autor:
William D. Spotnitz
The specialty of thoracic and cardiovascular surgery (TCV) has developed rapidly during the second half of the twentieth century. For this purpose, fibrin sealant is gaining increased popularity as a surgical tissue adhesive. Many of the major thorac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e4dd78bc1fa96b9e8a672f2d1b43242
https://doi.org/10.1201/9780429332500-28
https://doi.org/10.1201/9780429332500-28
Autor:
Stephanie Cavoores, Brian A. Bruckner, Patrick E. Parrino, Ian J. Shorn, Roberto J. Manson, Abbas Ardehali, Russell H Spotnitz, Nicholas C. Dang, Daniel L. Gillen, Rachel W Hoffman, William D. Spotnitz
Publikováno v:
Journal of cardiac surgery. 35(2)
AIM This trial compared the hemostatic performance of a novel combination powder (CP) to a control hemostatic matrix (HM) in cardiothoracic operations. METHODS Patients meeting eligibility criteria were enrolled after providing informed consent. Subj
Autor:
Patricia Forest, Dirk Zielske, Daniel L. Gillen, William D. Spotnitz, Catherine Wittmann, Valerie Centis, Doris Moura Campos, Paul C. McAfee, Alan Pearson, Vincent Guyot, Rachel W Hoffman
Publikováno v:
Spine. 43(11)
Study design Benchtop model with prospective surgeon video testing. Objective To create a surface bleeding severity scale, the SPOT GRADE (SG), for quantitative assessment of target bleeding site (TBS) blood loss. This is of particular interest for s
Autor:
William D. Spotnitz
Publikováno v:
ISRN Surgery
Background.Fibrin sealant became the first modern era material approved as a hemostat in the United States in 1998. It is the only agent presently approved as a hemostat, sealant, and adhesive by the Food and Drug Administration (FDA). The product is